Neoplasia intraneural ou extraneural que surge de tecidos nervosos e bainhas neurais. É composto por fibroblastos semelhantes ao perineurial e células de Schwann. Geralmente se apresenta como uma lesão cutânea localizada e menos frequentemente como uma massa nervosa periférica circunscrita. Pacientes com neurofibromatose tipo 1 apresentam múltiplas massas. Os neurofibromas que surgem dos principais nervos e os neurofibromas plexiformes são lesões precursoras de tumores malignos da bainha dos nervos periféricos.
Introdução
O que você precisa saber de cara
Neoplasia intraneural ou extraneural que surge de tecidos nervosos e bainhas neurais. É composto por fibroblastos semelhantes ao perineurial e células de Schwann. Geralmente se apresenta como uma lesão cutânea localizada e menos frequentemente como uma massa nervosa periférica circunscrita. Pacientes com neurofibromatose tipo 1 apresentam múltiplas massas. Os neurofibromas que surgem dos principais nervos e os neurofibromas plexiformes são lesões precursoras de tumores malignos da bainha dos nervos periféricos.
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 10 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 28 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Nenhum gene associado encontrado
Os dados genéticos desta condição ainda estão sendo catalogados.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Neurofibroma
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
18 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
339 ensaios clínicos encontrados, 31 ativos.
Publicações mais relevantes
Mostrando amostra de 200 publicações de um total de 2.010
Beyond nerve tumors: Differential diagnoses in suspected peripheral nerve sheath tumors.
A subset of patients with suspected peripheral nerve sheath tumors (PNSTs) are ultimately found to have non-neurogenic pathologies mimicking PNSTs. This study analyzed such "drop-out" cases from the German Peripheral Nerve Tumor Registry (PNTR) to identify diagnostic pitfalls, assess imaging value, and clarify the role of intraoperative and histological findings. This retrospective PNTR sub-study reviewed patients initially registered with suspected PNST who were later reclassified as "drop-out" cases due to intraoperative or histopathological findings inconsistent with PNST. Patients were treated at two high-volume nerve centers (University Hospital Essen and BKH Günzburg). Clinical data, imaging, surgical notes, and histopathology were analyzed descriptively, focusing on presentation, diagnostic discrepancies, nerve involvement, and surgical strategy. Of 590 registered patients, 50 (8.5%) were reclassified. The mean age was 50.8 years (range 19-90); 29 were men and 21 women. Most lesions were in the upper extremity (68%). Final diagnoses included benign soft tissue tumors (32%), malignant tumors (14%), inflammatory/immune-mediated (10%), non-neoplastic/reactive (10%), traumatic/regenerative neuromas (10%), cystic (10%), misdiagnoses/non-tumorous (10%), and vascular lesions (4%). Pain was the most frequent symptom (n = 33). Intraneural growth occurred mainly in inflammatory, reactive, and traumatic lesions, whereas non-PNSTs typically showed nerve contact only. Surgery ranged from fascicle biopsy to gross total resection. About one in twelve suspected PNSTs represented alternative pathologies. Red flags included absent intraneural growth, nonspecific pain, cubital tunnel clustering, and frequent biopsy need. Awareness of PNST mimics and meticulous imaging review are crucial to prevent misclassification and preserve function.
Prolonged Mitogen-Activated Protein Kinase Kinase (MEK) Inhibition Induces Increase in Proteolysis and Compensatory Phosphorylation of MEK and Protein Kinase B (AKT) in Plexiform Neurofibroma Cells.
Plexiform neurofibromas associated with neurofibromatosis type I (pNF1s) are benign tumors caused by the complete loss of function of the NF1 gene, which encodes a negative regulator of the RAS/mitogen-activated protein kinase (MAPK) pathway. pNF1s carry a significant risk of progression to malignant peripheral nerve sheath tumors (MPNSTs), which are highly aggressive and largely incurable. FDA-approved mitogen-activated protein kinase kinase (MEK) inhibitors, selumetinib and mirdametinib, have shown ~30% tumor shrinkage in 70% and 42% pNF1 patients, respectively. However, not all pNF1s respond to MEK inhibition, and treatment is often associated with adverse effects such as dermatologic and gastrointestinal toxicities, underscoring the need for improved therapeutic strategies with minimal side effects. Here, we demonstrate that prolonged MEK inhibition increases proteolytic activity in 3D pNF1 tumor structures, consistent with enhanced extracellular matrix degradation. Prolonged treatment with four mechanistically and chemically distinct MEK inhibitors consistently reduced ERK phosphorylation, a downstream effector of the RAS/MAPK pathway, yet induced adaptive phosphorylation of MEK and AKT in pNF1 tumor cells. Phosphorylation of MEK is required for its catalytic activation and subsequent phosphorylation of ERK. Increased MEK phosphorylation in the presence of MEK inhibitors reflects upstream pathway reactivation but does not lead to ERK phosphorylation and activation because of the presence of the inhibitor. This response was also observed in MPNST cell lines treated with MEK inhibitors. These findings suggest that adaptive activation of upstream and parallel survival pathways may counteract the intended effects of MEK inhibition and support the rationale for combination strategies to improve therapeutic outcomes in NF1-associated tumors.
Giant malignant peripheral nerve sheath tumor: Illustrative case and surgical technique.
Malignant peripheral nerve sheath tumors (MPNSTs) are one of the most difficult malignant mesenchymal neoplasms to treat. They can arise from a preexisting peripheral nerve sheath or in neurofibromatosis type 1 (NF1) patients. MPNSTs in the head-and-neck region represent approximately 2-6% of all head-and-neck sarcomas and account for 12-19% of all MPNSTs. It has an incidence of 0.001% in the general population, and prognosis is typically poor; only between 20% and 50% of patients survive 5 years after diagnosis. The complete surgical resection is recommended whenever possible. The authors report the case of a 31-year-old woman with a history of plexiform neurofibroma, who presented with recurrence with disease progression to MPNST, without association with NF1 disease. The aim of tumor resection is symptomatic relief. These tumors have a high risk of severe complications and even mortality due to various causes. The benefits - including the emotional ones - can be so significant that, despite their malignant lineage, resection and regrowth control remain worthwhile for as long as possible. Four- or six-hand surgery for these tumors can reduce bleeding, operative time, and complications.
Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II).
Neurofibromatosis type 1 (NF1)-associated plexiform neurofibroma (PN) can substantially affect quality of life. The capsule and granule formulations of selumetinib (ARRY-142886, AZD6244) are approved for pediatric patients with symptomatic, inoperable NF1-PN (age ≥1 to 3 years, region dependent). SPRINKLE (ClinicalTrials.gov identifier: NCT05309668) assessed pharmacokinetics (PK), safety, and palatability of the selumetinib granule formulation in children (age ≥1 to <7 years) with symptomatic, inoperable NF1-PN. Participants enrolled into Global Cohort (GC)1 (≥4 to <7 years), GC2 (≥1 to <4 years), or the Japan Cohort (JC; ≥1 to <7 years) received selumetinib 25 mg/m2 (dose equivalent) twice a day in 28-day cycles. Primary objectives assessed single-dose selumetinib PK exposure (area under concentration-time curve from time 0-12 hours [AUC0-12]) in GCs and selumetinib safety. Secondary objectives assessed selumetinib and N-desmethyl selumetinib metabolite PK (single/multiple dose), and palatability. At first data cutoff (April 8, 2024), all participants had completed ≥3 cycles. There were 36 participants (GC1: n = 15, GC2: n = 17, JC: n = 4). Geometric mean (95% CI) selumetinib AUC0-12 (single dose) in GC1 (n = 13) and GC2 (n = 15) was 1,902 (1,647 to 2,197) and 1,699 (1,436 to 2,009) h × ng/mL, respectively. Primary PK end point was met: 95% CIs of AUC0-12 (single dose) were within the acceptance range on the basis of the capsule formulation exposure. Median duration of exposure was approximately 11 months (range, 2.7-25.3). 97.2% of participants had ≥1 treatment-related adverse event; most were grade 1 or 2 and none led to discontinuation or dose reduction. Most participants reported swallowing the medication without problems. Selumetinib granule formulation (25 mg/m2 dose equivalent, twice a day) had comparable exposure to selumetinib capsule formulation, and was palatable with a manageable safety profile. Selumetinib granule formulation is potentially suitable for young children with NF1-PN who cannot swallow capsules.
HMGB1 affects the progression of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors through E2F2.
Malignant peripheral nerve sheath tumors (MPNSTs) represent the most severe complication of neurofibromatosis type 1 (NF1), with limited therapeutic options and poor prognosis. High-mobility group box 1 (HMGB1) is a chromatin-associated protein implicated in various cancers, yet its functional role and mechanistic involvement in NF1-MPNST progression remain poorly understood. We integrated single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq analyses of patient-derived NF1-MPNST and plexiform neurofibroma (PNF) tissues. Functional validation was performed using NF1 cell lines with HMGB1 knockdown and overexpression. Mechanistic insights were explored via CUT&Tag, ChIP‒qPCR, qPCR, and Western blot. In vivo tumor growth was assessed using a xenograft mouse model. HMGB1 was significantly upregulated in malignant CNV-high subpopulations of MPNSTs and correlated with poor patient survival. Functional assays demonstrated that HMGB1 knockdown suppressed tumor proliferation, migration, and invasion, and induced G1 arrest, while its overexpression promoted these phenotypes. Mechanistically, HMGB1 directly bound to the E2F2 promoter and activated its transcription, thereby driving the G1/S transition. In vivo, HMGB1 overexpression accelerated tumor growth, whereas knockdown suppressed it, consistent with modulated E2F2 and Ki-67 expression. Our study identifies HMGB1 as a key oncogenic driver in NF1-MPNST progression, functioning through direct transcriptional activation of E2F2 to promote cell cycle progression and tumor malignancy. These findings position HMGB1 as both a prognostic biomarker and a promising therapeutic target for NF1-associated MPNSTs.
Publicações recentes
Differentiation of MPNSTs from benign neurofibromas in neurofibromatosis patients using ADC and SUV biomarkers in children and young adults.
[Interpretation of the Expert Consensus for Full Course Management of Plexiform Neurofibroma (2025 Edition)].
Case Report: Appendiceal neurofibroma associated with neurofibromatosis type 1: a rare case and systematic review of the literature.
Near-Bloodless Resection of a Giant Hypervascular NF1-Associated Malignant Peripheral Nerve Sheath Tumor Using Dual-Modality Preoperative Embolization.
Challenges with Neural Anomalies in Hypoglossal Nerve Stimulator Implantation.
📚 EuropePMC2.514 artigos no totalmostrando 197
Benign Peripheral Nerve Sheath Tumors: Recurrence Rates and Pain Outcomes Following Excision.
Plastic and reconstructive surgeryBeyond nerve tumors: Differential diagnoses in suspected peripheral nerve sheath tumors.
Brain & spineBrachial plexus tumours: diagnosis, treatment, surgical approach and outcomes in 47 patients.
NeurocirugiaAdult patient and caregiver perspectives on the impact of NF1-PN: Insights from a US qualitative survey.
Neuro-oncology advancesLeft Inguino-Scrotal-Perineal Neurofibroma: A Report of a Rare Case and Review of Literature.
CureusA rare case report of solitary neurofibroma arising in the male breast.
International journal of surgery case reportsCase Report: Somatic NF2 mutation in a vestibular schwannoma arising in a patient with neurofibromatosis type 1.
Frontiers in oncologyThe Complexities of Periorbital Neurofibroma: Diagnostic Ambiguity and Therapeutic Dilemmas: A Case Report and Literature Review.
Diagnostics (Basel, Switzerland)Prolonged Mitogen-Activated Protein Kinase Kinase (MEK) Inhibition Induces Increase in Proteolysis and Compensatory Phosphorylation of MEK and Protein Kinase B (AKT) in Plexiform Neurofibroma Cells.
CellsStepping into clarity: high-resolution ultrasound unveils the hidden spectrum of ankle and foot pain.
Journal of ultrasoundAn Unsuspected Intraneural Perineurioma in a Pediatric Patient: A Case Report.
CureusMirdametinib in symptomatic neurofibromatosis type 1 plexiform neurofibromas.
Expert review of anticancer therapyCase Report: Parapharyngeal Leiomyosarcoma Mimicking Neurofibroma.
Clinical case reportsNeurofibromatosis type 1 with unilateral macrodactyly-like overgrowth: a case report.
Case reports in plastic surgery & hand surgery[Immunohistochemistry of melanocytic tumours].
Pathologie (Heidelberg, Germany)Precision restoration of complex cervical instability and decompression for neurofibromatosis type I: a case report using patient-specific 3D-printed templates.
Frontiers in surgeryIsolated Anterior Mesenteric Neurofibroma: A Rare Manifestation of Neurofibromatosis Type 1.
CureusGiant malignant peripheral nerve sheath tumor: Illustrative case and surgical technique.
Surgical neurology internationalA 17-Year-Old Male Adolescent With a Giant Isolated Scalp Neurofibroma Associated With a Calvarial Defect: A Case Report.
The American journal of case reportsSingle-cell transcriptomic profiling of malignant peripheral nerve sheath tumors.
Neuro-oncology advancesUnusual Presentation of Plexiform Neurofibroma Embedded with Large Comedones: A Case Report.
Case reports in dermatologyLarge Pleomorphic Adenoma of The Upper Lip in a Middle-Aged Woman With Facial Deformity, Tooth Displacement, and Bone Loss: Uncommon Clinical Presentation of a Benign Tumor.
Case reports in dentistryProof-of-principle of NF1 gene therapy in plexiform neurofibroma xenograft mouse models.
Communications biologyDiagnosis, treatment management, and challenges in neurofibromatosis type 1: a case report with mixed features.
Annals of medicine and surgery (2012)Laryngeal neurofibroma: case report and review of the literature.
Frontiers in oncologyEfficacy and Safety of Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1-Associated Plexiform Neurofibromas: Phase IIa Trial and Biomarker Research.
Clinical cancer research : an official journal of the American Association for Cancer ResearchImpaired Bone Healing and Fracture Complications during Limb Lengthening in a Neurofibromatosis Type 1 Patient Receiving Selumetinib: Case Report and Literature Review.
Journal of orthopaedic case reportsHepatic plexiform neurofibroma a rare manifestation of neurofibromatosis type 1: A case report and literature review.
Radiology case reportsMechanical Stiffening Promotes Growth, Invasion, and Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitor Resistance in 3D Plexiform Neurofibroma Cultures.
bioRxiv : the preprint server for biologyFatal Pericarditis and Cardiac Tamponade During Selumetinib Treatment for Pericardial Neurofibroma.
The Journal of dermatology[Neurofibromatosis 1-related tumors in pediatric patients].
Problemy endokrinologiiA rare case of plexiform neurofibroma.
Radiology case reportsInternal carotid artery sympathetic plexus neurofibroma - A case report.
Surgical neurology international[Clinical characteristics and genetic analysis of 22 Chinese pedigrees affected with Neurofibromatosis type I].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsPlexiform Neurofibroma of the Vulva in a Patient With Neurofibromatosis Type 1.
CureusDermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.
Journal of clinical medicinePharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II).
Journal of clinical oncology : official journal of the American Society of Clinical OncologyFAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.
Acta neuropathologicaHMGB1 affects the progression of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors through E2F2.
Cancer cell internationalClinical and Humanistic Burden Among Adults with Neurofibromatosis Type 1 and Symptomatic Plexiform Neurofibroma in the United States.
Neurology and therapyIsolated Neurofibroma of the Gallbladder and Common Bile Duct Mimicking Malignancy: A Rare Case Report and Review of Literature.
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chiBiallelic NF1 Inactivation and Widespread Loss of Heterozygosity in a Subset of Unclassified Fibromyxoid Mesenchymal Neoplasms.
Genes, chromosomes & cancerImmortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.
PloS oneNeurofibromatosis Type 1 in Ecuador: genotype-phenotype correlations from a case series.
MedwaveMicroenvironmental TGF-β is an early driver of NF1-associated tumor formation.
Cell reportsLarge Asymptomatic Schwannoma of the Tongue: An Unusual Case Report With Clinical, Radiologic, and Histopathological Correlation.
CureusPrevalence and management of lower limb segmental overgrowth in patients with NF1: an observational study.
Orphanet journal of rare diseasesDorsolumbar Junction Spinal Tumors at a Tertiary Care Center in Pakistan: Neurofibroma Predominance and Surgical Outcomes.
Pakistan journal of medical sciencesLong-term Stable Unilateral Mandibular Deformity Associated With Ipsilateral Skull-base Soft-tissue Lesion and Degenerated Pterygoid Muscles in Neurofibromatosis Type 1.
Cancer diagnosis & prognosisMalignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysis.
Neuro-oncology advancesThe Pathogenesis of the Neurofibroma-to-Sarcoma Transition in Neurofibromatosis Type I: From Molecular Profiles to Diagnostic Applications.
CancersMOIS-SAM2: Exemplar-based segment anything model 2 for multi-lesion interactive segmentation of neurofibromas in whole-body MRI.
Computers in biology and medicine[Detection of neurofibroma combining radiomics and ensemble learning].
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhiA Rare Case of Progressive and Invasive Adult Fibrosarcoma: Retroperitoneal Tumour Involving the Duodenum.
CureusSolitary diffuse-type giant neurofibroma arising from the sciatic nerve in a 13-year-old: A rare occurrence.
Oncoscience[Clinical characteristics and surgical management of primary intralabyrinthine tumor].
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgeryA Solitary Giant Neurofibroma of the Left Chest.
The Journal of craniofacial surgeryThe first year of treatment with selumetinib for NF1-related plexiform neurofibroma is medically challenging in real-life settings.
Annales de dermatologie et de venereologiePrimary ectopic meningioma of the brachial plexus: A case report and literature review.
Surgical neurology internationalPhenotypic characterization of neurofibromatosis type 1 in a large Chinese cohort: A cross-sectional study.
JAAD internationalPharmacokinetic-Based Dose Adjustment of Selumetinib in 2 Young Children With Neurofibroma.
Pediatric neurologyUnmasking benign intradural-extramedullary spinal tumors: a systematic review on treatment outcomes and radiological features.
Annals of medicine and surgery (2012)Retroperitoneal and pelvic schwannoma/neurofibroma resection: surgical strategies and outcomes in a neurosurgical cohort.
Acta neurochirurgicaBlurring the Lines: Co-Occurrence of MSH6 Variant and MLH1 Constitutional Epimutation in a Young Colorectal Cancer Patient.
Clinical geneticsAn Episcleral Lesion in a Patient With Neurofibromatosis Type 1.
Ophthalmic plastic and reconstructive surgeryDiagnostic challenges of the neurofibroma-malignant peripheral nerve sheath tumor spectrum in neurofibromatosis type 1: illustrative case.
Journal of neurosurgery. Case lessonsOptic Nerve Glioma, Plexiform Neurofibroma, and Secondary Glaucoma in a Child With a Rare NF1 Variant (p.Gln83Ter): A Case Report.
Cureus[Rare giant solitary vagus neurofibroma of the neck: a case report and literature review].
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgeryCervical dumbbell meningioma exhibiting distinct histopathological subtypes in intradural and extradural components: a case report.
BMC neurologyMalignant Peripheral Nerve Sheath Tumor Arising After Superficial Neurofibroma Excision: A Rare Sporadic Case in a Patient Without Neurofibromatosis Type 1.
CureusRadiological insights into orbital and periorbital plexiform neurofibromas in children with neurofibromatosis type 1.
Radiology case reportsA Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform Neurofibromas.
CPT: pharmacometrics & systems pharmacologyNeurofibromatosis review with focus on rehabilitation intervention.
Current problems in pediatric and adolescent health careHigh Allelic Heterogeneity in Kazakhstani Patients with Neurofibromatosis Type 1: Results from the First Molecular Study.
GenesStigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D.
The British journal of dermatologyPacinian Neurofibroma of Oral Cavity: A Rare Neurogenic Tumor.
Journal of dentistry (Shiraz, Iran)Hybrid neurofibroma/schwannoma in schwannomatosis-a diagnostically challenging benign peripheral nerve sheath tumour.
Familial cancerAnatomy-informed deep learning and radiomics for neurofibroma segmentation in whole-body MRI.
Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging SocietyMalignant peripheral nerve sheath tumors in schwannomatosis: a case series.
Journal of neurosurgeryCase Report of a Giant Mediastinal Neurofibroma Misdiagnosed as Massive Pleural Effusion.
Clinical case reportsNeurofibroma of the Posterior Ankle: A Case Report.
CureusOccipital Bone Defect With Meningoencephalocele and Plexiform Neurofibroma in Neurofibromatosis-1.
CureusEffect of Different Melanin-bleaching Methods on Staining.
Applied immunohistochemistry & molecular morphology : AIMMSOX11 is frequently expressed in ETV6::NTRK3-rearranged infantile fibrosarcoma and congenital mesoblastic nephroma.
Virchows Archiv : an international journal of pathologySalvage of necrotic flap following malignant peripheral nerve sheath tumor excision using multimodal pharmacotherapy: a case report.
Frontiers in oncologyAn Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas.
Journal of visualized experiments : JoVEPhase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform Neurofibromas.
Targeted oncologyMitogen-Activated Proteinkinase Kinase Inhibition Results in Rapid and Dramatic Shrinkage of a Facial Plexiform Neurofibroma in a 6-Month-Old Infant.
Pediatric neurologyIntraosseous Cellular Schwannoma in the Infraorbital Region: A Rare Case.
The American journal of case reportsRole of Peripheral Nerve Blocks for Management of Chronic Pain From Inoperable Neurofibromatosis Type 1-Associated Neurofibromas: A Case Report.
Pain medicine case reportsCutaneous Neufibroma in the Absence of Classical NF1 Features: A Case Report and Literature Review.
Dermatopathology (Basel, Switzerland)Temporomandibular joint ankylosis following bimaxillary surgery in a patient with neurofibromatosis type 1: a case report.
Oral and maxillofacial surgeryMultidisciplinary Management of Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis 1: Insights From Advisory Board-Guided Clinical Experience in Japan.
The Journal of dermatologyMirdametinib: FDA approved MEK inhibitor for neurofibromatosis type 1.
Cancer chemotherapy and pharmacologyA Retrospective Study of Diffuse Plexiform Neurofibroma With Surgical Intervention in Neurofibromatosis 1.
The Journal of dermatologyThe spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma.
Human geneticsCorrigendum for Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
The Journal of clinical investigationGlomus Tumour of Sciatic Nerve - A Rare Presentation Mimicking Sciatica.
Journal of orthopaedic case reportsGiant retroperitoneal solitary neurofibroma.
BMJ case reportsMeasurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASI.
Journal of the American Academy of DermatologyReviewer Comment on Ramaswamy et al. "A National Modified Delphi Consensus on the Referral and Management of NF1 Plexiform Neurofibroma".
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiquesA Unique Finding in an Adolescent Male: A Case Report Navigating in Detail about Oral Neurofibroma.
International journal of clinical pediatric dentistryThe skull base in NF1 phenotypes on lateral cephalograms.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial SurgeryJuvenile xanthogranuloma as a potential early manifestation of neurofibromatosis type 1: A case report.
MedicineCellular schwannoma of the base of tongue: A case report.
Journal of cancer research and therapeutics3D Model-Guided Robot-Assisted Giant Presacral Ganglioneuroma Exeresis by a Uro-Neurosurgeons Team: A Case Report.
Reports (MDPI)Therapeutic Advances in Neurofibromatosis Type 1: A Focus on Selumetinib.
Skin therapy letterAn evolving supraclavicular plaque: diagnostic challenges in dermatofibrosarcoma protuberans with atrophic and myxoid features.
Dermatology online journalDendritic Cell Neurofibroma With Pseudorosettes: A Case Report.
CureusSingle staged transorbital neuroendoscopic (TONES) approach of managing pulsatile proptosis using patient specific implant (PSI) in orbitopalpebral neurofibromatosis.
Orbit (Amsterdam, Netherlands)Targeted Therapies in Neurofibromatosis Type 1.
American journal of medical genetics. Part C, Seminars in medical geneticsPrevalence of Oral Alterations and Correlation Between Oral and Cutaneous Neurofibromas in Neurofibromatosis Type 1: A Retrospective Case-Control Study.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral PathologyMirdametinib, an FDA-Approved MEK1/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromas.
Expert opinion on investigational drugsCord Tethering By Plexiform Neurofibroma: A Rare Cause of Neurological Deficit in Dystrophic Scoliosis: A Case Report.
JBJS case connector[Single digit nail clubbing].
Nederlands tijdschrift voor geneeskundeSurgical Measures Improving Functional Limitations of the Masticatory System, Aesthetic Deficits, and Skeletal Malformations in Neurofibromatosis Type 1-associated Hemifacial Diffuse Plexiform Neurofibroma Complicated by Rapidly Growing Midfacial Peripheral Nerve Sheath Tumor.
Cancer diagnosis & prognosisHigh resolution nerve ultrasound in neurofibromatosis type 1: a prospective and descriptive study.
Clinical neurophysiology : official journal of the International Federation of Clinical NeurophysiologySelumetinib Treatment in a Neurofibromatosis Type 1 Child With Second Hit Mutation on the NF1 Gene.
International journal of developmental neuroscience : the official journal of the International Society for Developmental NeuroscienceA National Modified Delphi Consensus on the Referral and Management of NF1 Plexiform Neurofibroma.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiquesTreatment of giant encephalocele and occipital defect in a child with neurofibromatosis type 1: illustrative case.
Journal of neurosurgery. Case lessonsSacroiliac Joint Involvement: An Underreported Complication of NF1.
American journal of medical genetics. Part A'Alone on our NF1 island': a patient-led mixed-method survey study to understand the care pathway for neurofibromatosis type 1 (NF1) patients in the UK.
BMJ open qualityFibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.
CellsA Solitary Diffuse Neurofibroma in a Young Adult Female: An Unusual Presentation in the Scapular Region.
CureusMicroscopic Minimal Invasive Resection of Spinal Tumor with Tubular Retractor System: Case Studies of 70 Patients with Literature Review.
Asian journal of neurosurgeryA consensus on the diagnosis and management of neurofibromatosis type 1 in Taiwan.
Journal of the Formosan Medical Association = Taiwan yi zhiTrametinib in Adults with Neurofibromatosis Type 1-Related Symptomatic Plexiform Neurofibromas.
Annals of neurologyIsolated neurofibroma of the nasal vestibule: A rare case of the myxoid subtype and imaging-based differential diagnosis.
Radiology case reportsSolitary Neurofibroma in Lower Lip - A Case Report.
The Bulletin of Tokyo Dental CollegeReal-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study.
Journal of neuro-oncologyVisual Improvement in a Child With Periorbital Plexiform Neurofibroma Treated With Selumetinib: Case Report and Literature Review.
Ophthalmic plastic and reconstructive surgeryThe Morphologic Spectrum of NF Mutated Desmoplastic Melanocytic Neoplasms.
The American Journal of dermatopathologyRefined genotype-phenotype correlations in neurofibromatosis type 1 patients with NF1 point variants.
Journal of medical geneticsA Pediatric Case of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor of the Scalp.
Plastic and reconstructive surgery. Global openLuvometinib: First Approval.
DrugsProtein Kinase C-alpha Gene Fusions in Dendritic Cell Neurofibroma: Distinction From Conventional Neurofibroma.
The American journal of surgical pathologySelumetinib in Adult Neurofibromatosis 1 with Plexiform Neurofibroma.
Pharmaceuticals (Basel, Switzerland)Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control arm.
Neuro-oncology advancesNeurofibroma of Cecum with Ileocecal Granuloma.
Digestive diseases and sciencesGiant Atypical Neurofibroma of the Calf in Neurofibromatosis Type 1: Case Report and Literature Review.
Reports (MDPI)[New advances in the diagnosis and pharmacological treatment of plexiform neurofibromas associated with type 1 neurofibromatosis in children].
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgeryThe recurrence and multi-organ involvement of giant penile plexiform neurofibroma in an adult with neurofibromatosis type 1: a case report.
BMC urologyBreast carcinoma in a patient with neurofibromatosis type 1 and huge plexiform neurofibroma of the contralateral breast: a case report.
BMC women's healthAnterior vaginal wall neurofibroma in neurofibromatosis type 1 causing lower urinary tract symptoms.
BMJ case reportsUnraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.
Acta neuropathologica communicationsPigmented Birthmarks and Spinal Neurofibromas in KRAS Mosaicism-Not to Be Confused With NF1.
Pediatric dermatologyExcision of an Unexpected Retroperitoneal Mass at Laparoscopy.
CureusUtility of Genetic Testing of Various Tissues in Localized Mosaic Neurofibromatosis.
Acta dermatovenerologica Croatica : ADCExcision of a Solitary Neurofibroma in the Right Masseter Muscle via a High Perimandibular Approach: A Case Report and Review of the Literature.
Case reports in dentistryQualitative aspects of pain in children and adults with neurofibromatosis type 1 and plexiform neurofibromas: Causes, consequences, and communication.
Journal of health psychologyMalignant peripheral nerve sheath tumor in early childhood: a case report of a diagnostic challenge.
Frontiers in oncologySurgical management of giant neurofibroma in a pediatric patient: A case report.
Science progressSolitary intraoral pyogenic granuloma in neurofibromatosis type 1: diagnostic conundrum.
BMJ case reportsButtock Reconstruction With Hatchet-type Lumbosacral Flap After Resecting Diffuse Plexiform Neurofibroma With Methicillin Resistant Staphylococcus aureus-infected Intratumoral Hematoma.
Plastic and reconstructive surgery. Global openSingle-cell tumor microenvironment profiling informs a circulating proteome test for the interception of malignant transformation in NF1 nerve sheath tumors.
Research square[A clinical case of type 1 neurofibromatosis associated with a rare genotype].
Zhurnal nevrologii i psikhiatrii imeni S.S. KorsakovaPlexiform Schwannoma of the Foot: A Case Report.
CureusClinical Efficacy of Selumetinib in Alleviating Neuropathic Pain Associated with Plexiform Neurofibroma: A Case Series.
Genes[Analysis of clinical characteristics and NF1 gene variants in a child with Neurofibroma-Noonan syndrome].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsBrown Tumor of Hyperparathyroidism Presenting as Mandibular Mass.
The Journal of the Association of Physicians of IndiaSolitary Plexiform Neurofibroma in the Urachus Associated With von Recklinghausen's Disease.
CureusTGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma.
Science advancesPlexiform Neurofibroma Incidentally Detected by Chest X-ray.
Internal medicine (Tokyo, Japan)Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.
JID innovations : skin science from molecules to population healthAnesthetic management of endovascular embolization in a patient of neurofibromatosis with associated aortic and multisystemic vasculopathy: A case report.
Brain circulationAtypical presentations and neurosurgical Synergy in the treatment of paravertebral tumors in children: Lessons from a single institution.
Pediatrics and neonatologyPediatric Spindle Cell Tumor in Head and Neck Region: A Case Series.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaPlexiform Neurofibroma Versus Parotid Tumour - A Challenge in Management.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaEngineered AAV capsids mediate transduction of murine neurofibroma and sciatic nerve.
Gene therapyEnteric Neuromuscular Manifestations in Neurofibromatosis Type I.
Neurogastroenterology and motilityBeyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncEfficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study.
Lancet (London, England)Precision Medicine for Pediatric Glioma and NF1-Associated Tumors: The Role of Small Molecule Inhibitors.
Current oncology (Toronto, Ont.)Mirdametinib: First Approval.
DrugsDermatology images: Frequent cutaneous findings in neurofibromatosis type 1.
Journal of the American Academy of DermatologyNipple-Areolar Complex Neurotization Following Nipple-sparing Mastectomy and Breast Reconstruction for Solitary Breast Neurofibroma.
Plastic and reconstructive surgery. Global openIntraneural Neurofibroma.
Indian dermatology online journalMass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.
British journal of cancerPlexiform neurofibroma infiltrating uterine cervix and parametrium, causing hydronephrosis: A case report and review of the literature.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and ObstetricsTransorbital approach for a Meckel's cave hybrid benign tumor: operative video and technical nuances.
Neurosurgical focus: VideoCavernous malformation in the lumbar nerve rootlet.
Surgical neurology internationalBurkitt's lymphoma presenting as multiple nerve sheath tumors of the cauda equina.
Surgical neurology internationalSevere cervical kyphosis in a complex child with NF1, case report and literature review.
Child's nervous system : ChNS : official journal of the International Society for Pediatric NeurosurgeryTreatment of Plexiform Neurofibromas : Current Perspectives on Surgery and Medical Treatment.
Journal of Korean Neurosurgical SocietyRecurrent isolated orbital neurofibromas in the absence of NF1: Clinical insights and diagnostic challenges.
Clinical neuropathologyFacial Diffuse Plexiform Neurofibroma-associated Mandibular Deformities: Surgical Interventions and Monitoring of Treatment Results in a Patient for Over 40 Years.
Cancer diagnosis & prognosisRecurrent Diffuse Neurofibroma of the Mandibular Anterior Lingual Alveolar Process Associated With Dental and Skeletal Changes in Neurofibromatosis Type 1.
Cancer diagnosis & prognosisEndoscopic Ultrasonography Helps to Identify Benign Biliary Neurofibroma.
Digestive diseases and sciencesCase Report: Two cases of atypical neurofibroma neoplasm of uncertain biological potential in the nasal cavity and a literature review.
Frontiers in oncologyDevelopment of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.
Journal of patient-reported outcomesSurgical Management of Peripheral Nerve Schwannomas in Non-Neurofibromatosis Type 2 Schwannomatosis.
Operative neurosurgery (Hagerstown, Md.)Microcystic Pseudoglandular Cutaneous Neurofibroma: The First Japanese Case of a Rare Neurofibroma Variant.
The Journal of dermatologyChallenges of Selumetinib Therapy for Neurofibromatosis in a Resource-Limited Setting.
CureusIntracranial Hybrid Neurofibroma/Schwannoma Arising From the Olfactory Groove: A Report of an Extremely Rare Case and Review of the Literature.
CureusRare uro-genital manifestations of von Recklinghausen disease: Scrotal, penile, and intrapelvic involvement with bladder and spermatic cord extension: A case report.
Radiology case reportsMassive Plexiform Neurofibroma Involving Multiple Salivary Glands: A Rare Case Report.
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of IndiaSmall Intestinal Neurofibroma With Atypical 17q11.2 Microdeletions: A Rare Cause of Abdominal Distension.
JGH open : an open access journal of gastroenterology and hepatologyAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Neurofibroma.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Neurofibroma
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Beyond nerve tumors: Differential diagnoses in suspected peripheral nerve sheath tumors.
- Prolonged Mitogen-Activated Protein Kinase Kinase (MEK) Inhibition Induces Increase in Proteolysis and Compensatory Phosphorylation of MEK and Protein Kinase B (AKT) in Plexiform Neurofibroma Cells.
- Giant malignant peripheral nerve sheath tumor: Illustrative case and surgical technique.
- Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II).Journal of clinical oncology : official journal of the American Society of Clinical Oncology· 2026· PMID 41592259mais citado
- HMGB1 affects the progression of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors through E2F2.
- Differentiation of MPNSTs from benign neurofibromas in neurofibromatosis patients using ADC and SUV biomarkers in children and young adults.
- [Interpretation of the Expert Consensus for Full Course Management of Plexiform Neurofibroma (2025 Edition)].
- Case Report: Appendiceal neurofibroma associated with neurofibromatosis type 1: a rare case and systematic review of the literature.
- Near-Bloodless Resection of a Giant Hypervascular NF1-Associated Malignant Peripheral Nerve Sheath Tumor Using Dual-Modality Preoperative Embolization.
- Challenges with Neural Anomalies in Hypoglossal Nerve Stimulator Implantation.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:252183(Orphanet)
- MONDO:0016755(MONDO)
- GARD:7191(GARD (NIH))
- Busca completa no PubMed(PubMed)
- Q1418735(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
